HANNAH SAGEDY: Open Payments
NPI 1710350566 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,171 in 61 payments from 12 companies in 2025. Trend: 2023 $508 · 2024 $945 · 2025 $2,171
Food & beverage: $1,711Consulting: $350Education: $110
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 16 | $634 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $354 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $351 |
| AstraZeneca Pharmaceuticals LP | 12 | $292 |
| Novo Nordisk Inc | 1 | $122 |
| Lilly USA, LLC | 5 | $121 |
| Axsome Therapeutics, Inc. | 3 | $95 |
| HARMONY BIOSCIENCES LLC | 2 | $83 |
| Fisher & Paykel Healthcare Inc | 1 | $35 |
| Inspire Medical Systems, Inc. | 1 | $34 |
Products named: XYWAV, LUMRYZ, GLASSIA, FASENRA, Wegovy, ZEPBOUND, Sunosi, TEZSPIRE.
Industry payments across DC — which companies pay providers there.
